PharmTech News

Articles

IDT Biologika acquired Aeras' vaccine manufacturing facility, and the companies will work together on tuberculosis vaccine development.

Aeras and IDT Biologika Partner to Develop Vaccines

Kite announces that it will collaborate with bluebird bio to develop and commercialize second-generation T-cell receptor product candidates for HPV-associated cancers.

Kite Collaborates with bluebird bio to Develop T-Cell Therapy Products

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The ruling will facilitate the market entry of generic versions of Copaxone, a widely prescribed drug to treat multiple sclerosis.

Teva’s Patent for Copaxone Invalidated

Biomax Informatics AG and Pierre Fabre announced that they have entered into a collaboration to create an integrated antibody sequence and knowledge database.

Biomax Informatics Collaborates with Pierre Fabre on Therapeutic Antibody Development

GSK announces it will invest $95 million to launch a US-based non-profit research institute, Altius, to research technologies and approaches in understanding gene control.

GSK Invests $95 Million in Gene Control Research

Kythera announces that it entered into a definitive agreement to be acquired by Allergan for $2.1 billion.

Allergan Acquires Kythera for $2.1 Billion

The University of Pennsylvania announces that it will collaborate with WuXi AppTech to research and develop gene vectors derived from recombinant viruses.

Penn Announces Gene Therapy Collaboration with WuXi

At BIO 2015, CQDM and MaRS Innovation announced an investment in Encycle Therapeutics to research chemical properties needed to make peptide-like molecules orally bioavailable.

CQDM Invests with MaRS in Orally Bioavailable Peptide Drug Research

The exclusive manufacturing collaboration will establish production for adeno-associated virus gene-therapy treatments incorporating REGENXBIO’s NAV Technology.

REGENXBIO and WuXi AppTec Collaborate on Gene Therapy Manufacturing

Products on display include the newest addition to the Mobius line of single-use bioreactors; Cellvento CHO cell culture media for optimized production of specific cell lines; and new high-volume AFS water purification systems.

Bio/Pharma News